Evotec
Paolo Manzini is an Associate Scientist in Cell Therapy Process Development at Evotec since January 2023. Prior to this role, Paolo worked as a Graduate Research Fellow at Ospedale Policlinico di Milano from March 2020 to December 2022, contributing to projects in the Neural Stem Cell Lab and the Laboratory of Regenerative Medicine, with a focus on human induced pluripotent stem cells and extracellular vesicles. Previous experience includes internships at Università degli Studi di Modena e Reggio Emilia, where responsibilities involved the culture and isolation of stem cells and exosomes, and extraction and quantification of neurosteroids. Paolo holds a Laurea Magistrale in Biotecnologie Mediche and a Laurea triennale in Biologia/Scienze biologiche, both from Università degli Studi di Modena e Reggio Emilia.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.